Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,472 | 168 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $863.27 | 51 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $646.96 | 45 | $0 (2023) |
| RedHill Biopharma Inc. | $318.74 | 34 | $0 (2022) |
| Gilead Sciences, Inc. | $214.26 | 11 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $147.14 | 12 | $0 (2022) |
| Ardelyx, Inc. | $49.07 | 2 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $47.41 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $39.55 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $20.71 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $20.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $285.78 | 16 | ABBVIE INC. ($84.97) |
| 2022 | $1,181 | 85 | ABBVIE INC. ($411.39) |
| 2021 | $1,005 | 67 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($404.28) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.70 | General |
| Category: Neuroscience | ||||||
| 05/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Gastroenterology | ||||||
| 05/11/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Neuroscience | ||||||
| 05/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Gastroenterology | ||||||
| 05/03/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.26 | General |
| 04/19/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Gastroenterology | ||||||
| 04/15/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: VIROLOGY | ||||||
| 04/13/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Immunology | ||||||
| 04/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/23/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/31/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 01/27/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.28 | General |
| 01/03/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.01 | General |
| 12/06/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.07 | General |
| 11/30/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.09 | General |
| 11/10/2022 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/10/2022 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2022 | Cumberland Pharmaceuticals, Inc. | KRISTALOSE (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2022 | RedHill Biopharma Inc. | Talicia (Drug), Aemcolo | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Antibiotic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 125 | 129 | $30,050 | $9,606 |
| 2022 | 7 | 169 | 184 | $38,884 | $14,611 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 69 | $20,500 | $6,766 | 33.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 19 | 19 | $2,850 | $955.32 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $3,325 | $949.93 | 28.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 27 | 27 | $3,375 | $934.74 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 69 | $18,020 | $7,195 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $5,295 | $2,013 | 38.0% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 21 | 22 | $3,300 | $1,625 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 17 | $4,550 | $1,455 | 32.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 16 | 16 | $3,619 | $947.10 | 26.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 23 | 24 | $3,000 | $835.20 | 27.8% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2022 | 21 | 22 | $1,100 | $541.50 | 49.2% |
About Justin Titus, PA
Justin Titus, PA is a Physician Assistant healthcare provider based in Elmhurst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2018. The National Provider Identifier (NPI) number assigned to this provider is 1316413651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Justin Titus, PA has received a total of $2,472 in payments from pharmaceutical and medical device companies, with $285.78 received in 2023. These payments were reported across 168 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,472).
As a Medicare-enrolled provider, Titus has provided services to 294 Medicare beneficiaries, totaling 313 services with total Medicare billing of $24,217. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Elmhurst, NY
- Active Since 10/14/2018
- Last Updated 10/14/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1316413651
Products in Payments
- XIFAXAN (Drug) $624.90
- Talicia (Drug) $280.36
- SKYRIZI (Biological) $268.64
- HUMIRA (Biological) $156.90
- LINZESS (Drug) $154.61
- CIMZIA (Drug) $147.14
- RINVOQ (Biological) $105.48
- CREON (Drug) $87.74
- MAVYRET (Drug) $72.30
- IBSRELA (Drug) $49.07
- Aemcolo (Drug) $38.38
- ZEPOSIA (Drug) $32.70
- ENTYVIO (Biological) $23.97
- TRULANCE (Drug) $22.06
- DIFICID (Drug) $20.71
- STELARA (Biological) $20.00
- REMICADE (Biological) $19.55
- Zelnorm (Drug) $19.00
- VRAYLAR (Drug) $17.60
- CERDELGA (Drug) $17.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Elmhurst
Emmanuel Agnant, Pa, PA
Physician Assistant — Payments: $42,701
Noelia Cilli, Pa-C, PA-C
Physician Assistant — Payments: $8,381
Margarita Karpman, Pa, PA
Physician Assistant — Payments: $5,961
Miss. Christina Alvarez, Pa-C, PA-C
Physician Assistant — Payments: $5,242
Rosemary Perez
Physician Assistant — Payments: $5,047
Ariel Dai, Pa, PA
Physician Assistant — Payments: $4,447